Beryl Drugs is not listed on NSE
AnnouncementsBeryl Drugs: Board to consider dividend
AnnouncementsBeryl Drugs: Outcome of board meeting
52 Week HighBeryl Drugs has hit a 52wk high of Rs 48.00 on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 41.90 on BSE
No recommendations so far.What's your call on Beryl Drugs today?
|Company Name||Last Price||%
|Dr Reddys Labs||2979.00||0.61||3025.50||2286.80||50,751.98|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Beryl Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 14.56 crore.The company has reported a standalone sales of Rs 3.65 crore and a Net Profit of Rs 0.07 crore for the quarter ended Jun 2014.
The company management includes Sanjay Sethi - Chairman & Managing Director, Sudhir Sethi - Whole Time Director, Sunil Jain - Director, Hemant Jain - Director, Avinash Sharma - Director, Bagachand Jain - Director.
It is listed on the BSE with a BSE Code of 524606.
Its Registered office is at 133, Kanchan Bag , Indore,Madhya Pradesh - 452001.
Their Registrars are Adroit Corporate Service (P) Ltd.